These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31867844)

  • 1. Economic impact of keratoconus using a health expenditure questionnaire: A patient perspective.
    Chan E; Baird PN; Vogrin S; Sundararajan V; Daniell MD; Sahebjada S
    Clin Exp Ophthalmol; 2020 Apr; 48(3):287-300. PubMed ID: 31867844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lifetime economic burden of keratoconus: a decision analysis using a markov model.
    Rebenitsch RL; Kymes SM; Walline JJ; Gordon MO
    Am J Ophthalmol; 2011 May; 151(5):768-773.e2. PubMed ID: 21310384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus.
    Godefrooij DA; Mangen MJ; Chan E; O'Brart DPS; Imhof SM; de Wit GA; Wisse RPL
    Ophthalmology; 2017 Oct; 124(10):1485-1495. PubMed ID: 28532974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis.
    Leung VC; Pechlivanoglou P; Chew HF; Hatch W
    Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal collagen cross-linking for treating keratoconus.
    Sykakis E; Karim R; Evans JR; Bunce C; Amissah-Arthur KN; Patwary S; McDonnell PJ; Hamada S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010621. PubMed ID: 25803325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic cost of myopia in adults aged over 40 years in Singapore.
    Zheng YF; Pan CW; Chay J; Wong TY; Finkelstein E; Saw SM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7532-7. PubMed ID: 24159089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Keratoconus Based on Scheimpflug Imaging: The Raine Study.
    Chan E; Chong EW; Lingham G; Stevenson LJ; Sanfilippo PG; Hewitt AW; Mackey DA; Yazar S
    Ophthalmology; 2021 Apr; 128(4):515-521. PubMed ID: 32860813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert panel on practice patterns in the management of cow's milk protein allergy and associated economic burden of disease on health service in Turkey.
    Sekerel BE; Seyhun O
    J Med Econ; 2017 Sep; 20(9):923-930. PubMed ID: 28602101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort.
    Close S; Marshall-Gradisnik S; Byrnes J; Smith P; Nghiem S; Staines D
    Front Public Health; 2020; 8():420. PubMed ID: 32974259
    [No Abstract]   [Full Text] [Related]  

  • 11. The societal burden of haemophilia A. II - The cost of moderate and severe haemophilia A in Australia.
    Brown LJ; La HA; Li J; Brunner M; Snoke M; Kerr AM
    Haemophilia; 2020 Aug; 26 Suppl 5():11-20. PubMed ID: 32935398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of vision-related quality of life in keratoconus patients, and associated impact of keratoconus severity indicators.
    Panthier C; Moran S; Bourges JL
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1459-1468. PubMed ID: 32296993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost impact of high staff turnover on primary care in remote Australia.
    Zhao Y; Russell DJ; Guthridge S; Ramjan M; Jones MP; Humphreys JS; Wakerman J
    Aust Health Rev; 2019 Jan; 43(6):689-695. PubMed ID: 30158049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on treatment of secondary keratoconus with special designed rigid gas permeable contact lens].
    Wang D; Xie PY; Zhou JL
    Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):327-33. PubMed ID: 23900092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional analysis of out-of-pocket expenses for people living with a cancer in rural and outer metropolitan Western Australia.
    Slavova-Azmanova NS; Newton JC; Johnson CE; Hohnen H; Ives A; McKiernan S; Platt V; Bulsara M; Saunders C
    Aust Health Rev; 2021 Mar; 45(2):148-156. PubMed ID: 33587885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus.
    Keane M; Coster D; Ziaei M; Williams K
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009700. PubMed ID: 25055058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The excess cost of depression in South Australia: a population-based study.
    Hawthorne G; Cheok F; Goldney R; Fisher L
    Aust N Z J Psychiatry; 2003 Jun; 37(3):362-73. PubMed ID: 12780477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Costs of Diseases and Deaths Attributable to Tobacco Use in India, 2017-2018.
    John RM; Sinha P; Munish VG; Tullu FT
    Nicotine Tob Res; 2021 Jan; 23(2):294-301. PubMed ID: 32805055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.